Fatal pulmonary embolism after hemodialysis vascular access declotting

Abstract

Patient: Male, 59Final Diagnosis: Pulmonary embolismSymptoms: Cardiac arrest • chest pain • dyspneaMedication: —Clinical Procedure: AngioplastySpecialty: NephrologyObjective:Rare diseaseBackground:Vascular access is the lifeline of hemodialysis patients and access problems are a major source of morbidity and mortality for these patients. Access stenosis and thrombosis are common problems in dialysis patients and require prompt intervention. Every year thousands of these procedures are performed in the United States by radiologists, surgeons, and interventional nephrologists.Case Report: A 59-year-old man on chronic hemodialysis with multiple medical problems, including diabetes mellitus, hypertension, chronic obstructive lung disease, hepatitis C infection, and end-stage renal disease, who had clotted his access several times before ,presented with another episode of access clotting. He underwent declotting successfully but upon angioplasty of the access feeding artery, he developed massive pulmonary embolism and died. Postmortem examination showed multiple pulmonary emboli, including cholesterol crystals in his lungs.Conclusions:Hemodialysis access declotting and angioplasty are usually benign and do not cause a major problem. However, occasionally they become complicated. In difficult cases and in people with multiple comorbidities, it is preferable to forego the existing dialysis access and either plan for creation of a new vascular access or place a central vein catheter.

Manual compression technique improves the success rate in the treatment of thrombosed aneurysmal arteriovenous fistula: A single‐center experience

“…Unlike surgical thrombectomy to remove thrombi, MCT and traditional PTA mainly use fragmentation and thrombolysis to manage thrombi. Therefore, the most serious complication, pulmonary embolism, 13–15 is a major concern. Thrombus reduction must be optimized before or during MCT.…”

“…6 Although these devices have the advantage of being less invasive, the problem of these devices is that they are very expensive (over 100,000 Taiwan dollars), are not Unlike surgical thrombectomy to remove thrombi, MCT and traditional PTA mainly use fragmentation and thrombolysis to manage thrombi. Therefore, the most serious complication, pulmonary embolism, [13][14][15] is a major concern. Thrombus reduction must be optimized before or during MCT.…”

A Case of Brachial Artery Thrombosis Caused by Massage of an Occluded Arteriovenous Graft

“…The benefit of this procedure is that it can be performed immediately after a thrombotic occlusion occurs. At the same time, a risk associated with the procedure is that the dispersal of a coarse thrombus to a central site may lead to the development of a pulmonary embolism [8], whereas thrombi dispersing to the periphery represent a risk of brachial, ulnar, and radial artery occlusion, as seen Immediately after surgery, the color of the fingers improved. Heparin at 500 unit/hour was infused intravenously after surgery.…”

Lethal Pulmonary Embolism Following Left Upper Extremity Angiogram/Angioplasty with Thrombectomy at Malfunctioning Arteriovenous Fistula

“…Unless patients have a patent foramen ovale or some other cardiopulmonary defect, systemic embolization causing a serious cardiovascular accident is rare. The vast majority of clots that embolize the lungs are small enough to remain asymptomatic and they spontaneously resorb [5].…”